tiprankstipranks
Trending News
More News >
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
Advertisement

Nuvectis Pharma (NVCT) Technical Analysis

Compare
106 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Nuvectis Pharma’s (NVCT) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Nuvectis Pharma is a Sell.
Nuvectis Pharma’s (NVCT) 20-Day exponential moving average is 6.73, while Nuvectis Pharma’s (NVCT) share price is $6.85, making it a Buy.
Nuvectis Pharma’s (NVCT) 50-Day exponential moving average is 7.31, while Nuvectis Pharma’s (NVCT) share price is $6.85, making it a Sell.

Nuvectis Pharma (NVCT) Pivot Points

Aug 28, 2025, 05:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.93
6.20
6.35
6.62
6.77
7.04
7.19
Fibonacci
6.20
6.36
6.46
6.62
6.78
6.88
7.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Nuvectis Pharma (NVCT) Moving Averages

Aug 28, 2025, 05:15 PM
Period
Simple
Exponential
MA5
6.62Buy
6.64Buy
MA10
6.49Buy
6.59Buy
MA20
6.60Buy
6.73Buy
MA50
7.37Sell
7.31Sell
MA100
8.32Sell
7.70Sell
MA200
7.51Sell
7.33Sell
Nuvectis Pharma’s (NVCT) 10-Day exponential moving average is 6.59, while Nuvectis Pharma’s (NVCT) share price is $6.85, making it a Buy.
Nuvectis Pharma’s (NVCT) 100-Day exponential moving average is 7.70, while Nuvectis Pharma’s (NVCT) share price is $6.85, making it a Sell.
Nuvectis Pharma’s (NVCT) stock price is $6.85 and Nuvectis Pharma’s (NVCT) 50-day simple moving average is 7.37, creating a Sell signal.
Nuvectis Pharma’s (NVCT) stock price is $6.85 and Nuvectis Pharma’s (NVCT) 100-day simple moving average is 8.32, creating a Sell signal.
Nuvectis Pharma’s (NVCT) stock price is $6.85 and Nuvectis Pharma’s (NVCT) 200-day simple moving average is 7.51, creating a Sell signal.

Nuvectis Pharma (NVCT) Technical Indicators

Aug 28, 2025, 05:15 PM
Name
Value
Implied Action
RSI (14)
49.55
Neutral
STOCH (9,6)
74.41
Neutral
STOCHRSI (14)
70.03
Neutral
MACD (12,26)
-0.26
Sell
ADX (14)
21.96
Neutral
Williams %R
-12.28
Sell
CCI (14)
22.60
Neutral
ATR (14)
0.47
-
Ultimate Oscillator
57.75
Neutral
ROC
6.04
Buy
Nuvectis Pharma’s (NVCT) Relative Strength Index (RSI) is 49.55, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Trend Strength Indicator (ADX) is 21.96, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Commodity Channel Index (CCI) is 22.60, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Price Rate of Change (ROC) is 6.04, creating a Buy signal.

FAQ

Is NVCT a Buy, Hold, or Sell?
Based on NVCT’s technical indicators, NVCT is a Hold.
    What is NVCT’s RSI (14)?
    NVCT’s RSI (14) is 49.55, which suggests NVCT is a Neutral.
      What is NVCT’s MACD?
      NVCT’s MACD is -0.26, which suggests NVCT is a Sell.
        What is NVCT’s 5-day moving average?
        NVCT’s 5-day moving average is 6.62, which suggests NVCT is a Buy.
          What is NVCT’s 20-day moving average?
          NVCT 20-day moving average is 6.60, which suggests NVCT is a Buy.
            What is NVCT’s 50-day moving average?
            NVCT’s 50-day moving average is 7.37, which suggests NVCT is a Sell.
              What is NVCT’s 200-day moving average?
              NVCT’s 200-day moving average is 7.51, which suggests NVCT is a Sell.
                What is NVCT’s Williams % R (14)?
                NVCT’s Williams % R (14) is -12.28, which suggests NVCT is a Sell.
                  What is NVCT’s CCI (14)?
                  NVCT’s CCI (14) is 22.60, which suggests NVCT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis